a timeof change
Judy Shepard
helped make a hatecrimes bill law duringa year to remember.
PAGE 12
nightlifeagenda
Join
Mike Manning
from ‘Real World D.C.’as Halo marks itsname change to MOVA.
PAGE 20
districtagenda
An update on effortsby anti-gay activiststo undo marriagerights in the city.
PAGE 5
dcagenda
the lgbtq community’s news source
dcagenda.com • vol. 1, issue 7 • january 1, 2010
2009 Year in Review
More celebration and heartbreak in fight for marriage rights,
page 10
2 dcagenda.com • january 1, 2010
INDICATIONS
ISENTRESS is an anti-HIV medicine used for the treatment of HIV.
ISENTRESS must be used with other anti-HIV medicines
, which may increase the likelihood of response to treatment.The safety and effectiveness of ISENTRESS in children has not been studied.It is important that you remain under your doctor’s care.ISENTRESS will NOT cure HIV infection or reduce your chance of passing HIV to others through sexualcontact, sharing needles, or being exposed to your blood.
IMPORTANT RISK INFORMATION
A condition called Immune Reconstitution Syndrome can happen in some patients with advanced HIVinfection (AIDS) when anti-HIV treatment is started. Signs and symptoms of inammation from opportunisticinfections may occur as the medicines work to treat the HIV infection and strengthen the immune system.Call your doctor right away if you notice any signs or symptoms of an infection after starting ISENTRESS.Contact your doctor immediately if you experience unexplained muscle pain, tenderness, or weakness whiletaking ISENTRESS. This is because on rare occasions muscle problems can be serious and can lead tokidney damage.When ISENTRESS has been given with other anti-HIV drugs, the most common side effects included nausea,headache, tiredness, weakness, and trouble sleeping.
january 1, 2010 • dcagenda.com 3
Call 1-866-350-9232
Need help paying for ISENTRESS?
You are special, unique, and different from anyone else. And so is yourpath to managing HIV. When you’re ready to start HIV therapy, talk to your doctor about a medication that may fit your needs and lifestyle.
In clinical studies lasting 48 weeks, patients being treated with HIV medication for the rst time who tookISENTRESS plus
Truvada
:Had a low rate of side effects—In 4% of patients taking ISENTRESS plus
Truvada
versus 3% taking
Sustiva
plus
Truvada
, themost commonly reported side effect of moderate to severe intensity (that interfered with or keptpatients from performing daily activities) was trouble sleeping Experienced less effect on LDL cholesterol (“bad” cholesterol)—Cholesterol increased an average of 6 mg/dL with ISENTRESS plus
Truvada
versus 16 mg/dLwith
Sustiva
plus
Truvada
Ask your doctor about ISENTRESS.
isentress.com
People taking ISENTRESS may still develop infections, including opportunistic infections or other conditionsthat occur with HIV infection.Tell your doctor about all of your medical conditions, including if you have any allergies, are pregnantor plan to become pregnant, or are breast-feeding or plan to breast-feed. ISENTRESS is not recommendedfor use during pregnancy. Women with HIV should not breast-feed because their babies could be infectedwith HIV through their breast milk.Tell your doctor about all the medicines you take, including prescription medicines like rifampin (a medicineused to treat infections such as tuberculosis), non-prescription medicines, vitamins, and herbal supplements.You are encouraged to report negative side effects ofprescription drugs to the FDA. Visit www.fda.gov/medwatch,or call 1-800-FDA-1088.For more information about ISENTRESS, pleaseread the Patient Information on the following page.
ISENTRESS is a registered trademark of Merck & Co., Inc.Copyright © 2009 Merck & Co., Inc. All rights reserved.20953087(10)(106)-ISN-CON
Sustiva
is a registered trademark of Bristol-Myers Squibb
Truvada
is a registered trademark of Gilead Sciences, Inc.
Search History:
Result 00 of 00
00 results for result for
p.
dcagenda.com - vol. 2 issue 1 - january 1, 2010
1.7K
Reads
1
Readcasts
1
Embed Views
Recommended
More From This User
Notes
Load more
